title: Transparency of funding of patient groups is mandatory but is not enough.
authors.affiliation: Laboratory for Medical Research and Consumer Involvement, Department of Public Health, IRCCS-Mario Negri Institute for Pharmacological Research, Milan, Italy Cinzia.colombo@marionegri.it.
authors.forename: Cinzia
authors.initials: C
authors.lastname: Colombo
authors.affiliation: Laboratory for Medical Research and Consumer Involvement, Department of Public Health, IRCCS-Mario Negri Institute for Pharmacological Research, Milan, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Mosconi
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D002185:Cannabidiol / Q000627:therapeutic use*; D002202:Capital Financing; D002608:Charities / Q000191:economics*; D013759:Dronabinol / Q000627:therapeutic use*; D004345:Drug Industry; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*
chemical_list: D000700:Analgesics; D002185:Cannabidiol; D013759:Dronabinol